Fact-checked by Grok 2 weeks ago

Rapid sequence induction

Rapid sequence induction (RSI), also known as rapid sequence intubation, is a standardized designed to secure a patient's airway swiftly and safely in settings where there is a heightened risk of of gastric contents. It involves preoxygenation followed by the simultaneous administration of a rapid-acting induction agent to induce and a neuromuscular blocking agent to facilitate , enabling immediate endotracheal without intervening bag-mask to minimize the unprotected airway period. This technique is the preferred method for in scenarios such as , obstetric emergencies, and critical care, where patients may not be fasted and remains a leading cause of anesthesia-related morbidity and mortality. The procedure's origins trace back to the mid-20th century, prompted by observations of aspiration syndromes in , with key developments including the 1946 description of Mendelson's syndrome and the 1961 introduction of cricoid pressure by Sellick to occlude the . By 1970, Stept and formalized RSI as a 15-step process, establishing it as a cornerstone of emergency that has evolved into the in emergency departments for over four decades. Modern RSI emphasizes meticulous preparation, including airway assessment using tools like the MACOCHA score to identify difficult airways, assembly of equipment such as videolaryngoscopes, and clear team roles to mitigate risks like or . Indications for RSI include inability to maintain airway patency, failure to protect the airway due to altered consciousness, inadequate ventilation or oxygenation, and anticipated clinical deterioration in conditions like , , or severe . Key components involve preoxygenation with 100% oxygen for three minutes or eight vital capacity breaths, application of cricoid (approximately 30 Newtons) during to further reduce risk—though its efficacy remains debated—and of tube placement via waveform capnography. Post- care includes and analgesia to maintain comfort. Despite its effectiveness, RSI carries risks, including a failed rate of about 1 in 300 cases, particularly in vulnerable populations, underscoring the need for backup airway strategies and adherence to guidelines like those from the Practical Universal Modified Airway () framework established in 2019.

Definition and Principles

Definition

Rapid sequence induction (RSI) is an emergency medical procedure designed to secure a patient's airway through endotracheal as quickly as possible, primarily to minimize the risk of in individuals with a full or compromised protective reflexes. It involves the near-simultaneous intravenous administration of a rapidly induction agent to achieve and a neuromuscular blocking agent to induce , facilitating prompt placement of a cuffed endotracheal tube. This technique is widely employed in emergency departments, critical care settings, and prehospital environments where rapid airway control is essential for patients in acute respiratory distress or at high aspiration risk. A key distinction of RSI from standard rapid induction techniques lies in the deliberate avoidance of manual bag-mask between the of induction and paralytic agents and the subsequent attempt. This omission prevents gastric , which could increase intra-abdominal pressure and exacerbate risk, unlike elective inductions where may be titrated or provided to maintain oxygenation. The core components of RSI include preoxygenation to maximize oxygen reserves, the swift delivery of pharmacologic agents, and immediate for , all executed in a coordinated manner to optimize success rates while prioritizing . Over the decades, RSI has evolved into a standardized approach in , supported by extensive clinical evidence for its efficacy in high-stakes .

Core Principles

Rapid sequence induction (RSI) primarily aims to secure a definitive airway in patients at high risk of , such as those with a full or , by rapidly inducing and to facilitate endotracheal . This approach protects the airway during the critical period when protective reflexes are lost, minimizing the chance of regurgitation or vomiting in non-fasted individuals. By achieving quick control, RSI reduces the overall risk of aspiration-related complications in settings. The physiological basis of RSI centers on minimizing the duration of the unprotected interval between the loss of airway reflexes and tube placement, thereby preventing gastric contents from entering the lungs. This brief timeframe is essential for patients with altered mental status or acute , where delayed could exacerbate or . The technique leverages the apneic period post-induction to maintain negative intragastric pressure, avoiding maneuvers that might promote . Central to RSI is the principle of "crash" intubation without bag-mask ventilation, which eliminates positive pressure that could increase gastric insufflation and aspiration risk in high-risk patients. This avoidance of ventilation during the procedure underscores RSI's focus on rapid, uninterrupted progression to intubation, particularly beneficial for trauma victims or those unable to fast. Overall, these elements ensure effective airway protection while prioritizing speed and safety.

Indications and Contraindications

Indications

Rapid sequence induction (RSI) is indicated in clinical scenarios requiring urgent airway securing to protect against aspiration and ensure rapid control, particularly in emergency settings such as trauma, cardiac arrest, and status epilepticus. In trauma patients, RSI facilitates immediate airway management amid risks of cervical spine injury and hemodynamic instability, optimizing intubation success while minimizing manipulation. For cardiac or respiratory arrest, RSI is employed when endotracheal intubation is necessary to support ventilation, especially in cases of failed basic airway maneuvers or impending airway loss due to decreased consciousness. Similarly, in status epilepticus, RSI enables swift airway protection and ventilation to prevent hypoxia and facilitate anticonvulsant administration, with agents like ketamine preferred for their antiseizure properties. Patients at risk of aspiration due to a full represent another primary indication for RSI, including those with recent food intake, gastrointestinal obstruction, or conditions causing delayed gastric emptying such as use or . In such cases, RSI minimizes the time between loss of consciousness and airway securing, reducing regurgitation and risks; for instance, heightens intra-abdominal pressure, exacerbating potential. further increases aspiration likelihood due to progesterone-mediated lower esophageal relaxation and delayed emptying, making RSI the standard for emergency cesarean sections or non-obstetric procedures. contribute by slowing gastric , compounding risks in critically ill patients.30565-6/fulltext) RSI is also preferred for non-cooperative patients exhibiting , combativeness, or inability to tolerate awake intubation techniques, as these behaviors hinder standard preoxygenation and increase procedural risks. In or delirious individuals, medication-assisted RSI allows for controlled and , improving safety in or settings. The Society of Critical Care Medicine (SCCM) 2023 guidelines recommend RSI for critically ill adults in the ICU or , emphasizing its role in optimizing conditions and reducing complications in these high-risk populations.

Contraindications

Rapid sequence induction (RSI) has few absolute contraindications, primarily centered on scenarios where securing the airway poses an insurmountable risk without alternative interventions. Complete upper airway obstruction, such as that caused by severe or impaction, represents an absolute contraindication, as it necessitates an immediate surgical airway rather than RSI to avoid catastrophic . Similarly, a predicted difficult airway in which backup ventilation via bag-valve-mask is deemed impossible—due to anatomical distortions from , tumors, or burns—precludes RSI, as the technique assumes the ability to rapidly intubate following . Relative contraindications to RSI include conditions where the procedure could exacerbate underlying physiological derangements, though these may be mitigated with modifications. Severe hemodynamic instability, exemplified by , is a relative because induction agents may precipitate cardiovascular collapse through or myocardial depression, particularly if volume is incomplete. In such cases, RSI proceeds only after optimizing and selecting hemodynamically neutral agents like or . Additionally, an anticipated difficult airway without guaranteed oxygenation qualifies as relative, prompting consideration of techniques to preserve spontaneous breathing. In high-risk cases, alternatives to RSI prioritize airway security while minimizing complications. Awake intubation, facilitated by topical anesthesia and sedation, is recommended when difficult airway features are identified, allowing preservation of patient ventilation until the airway is secured. Video laryngoscopy enhances visualization and success rates in predicted difficult scenarios, serving as an adjunct or primary method over direct laryngoscopy. For absolute obstructions or failed nonsurgical attempts, an emergency surgical airway, such as cricothyrotomy, becomes the definitive alternative. Recent guidelines underscore the importance of pre-assessment to identify contraindications early. The Difficult Airway Society 2025 guidelines emphasize comprehensive airway evaluation—including history, bedside tests like the upper lip bite test, and imaging such as —prior to RSI, to stratify risk and select appropriate strategies, thereby reducing unanticipated failures.

Pharmacology

Premedication Agents

Premedication agents in rapid sequence induction (RSI) are pharmacologic interventions administered to attenuate specific adverse physiological responses, such as hemodynamic fluctuations or , that may arise during and . These agents are selected based on patient-specific risks, such as or pediatric age, and are given intravenously 3-5 minutes prior to the induction phase to optimize their onset while minimizing delays in the time-critical RSI process. Lidocaine, administered at a dose of 1.5 mg/kg intravenously over 2-3 minutes, serves to blunt the sympathetic stimulation and potential rise in (ICP) triggered by , making it particularly relevant for patients with . This timing allows for peak effect during , with a duration of action of approximately 10-20 minutes. Although historically recommended, systematic reviews indicate limited evidence supporting its efficacy in preventing ICP elevations during RSI in head-injured adults, suggesting its use should be judicious. Fentanyl, dosed at 1-3 mcg/kg intravenously and administered slowly to avoid rapid onset of side effects, mitigates the catecholamine surge and sympathetic responses—such as and —associated with . This premedication is especially beneficial in patients with hemodynamic instability, , or elevated , where blunting these responses can prevent secondary injury. However, higher doses carry a risk of , particularly in hypovolemic or critically ill individuals, necessitating careful . Its short duration aligns with the RSI timeline, providing analgesia without prolonged respiratory depression when used judiciously. In pediatric RSI, atropine at 0.02 mg/kg intravenously (with a minimum dose of 0.1 mg) is traditionally employed to counteract vagal stimulation and induced by succinylcholine, especially in infants under 1 year or during repeat dosing. This agent is administered 3-5 minutes before induction to preemptively increase stability. from randomized studies, however, shows that routine atropine does not significantly decrease incidence in children undergoing RSI with succinylcholine. The 2020 Pediatric Advanced Life Support (PALS) guidelines endorse its consideration only in high-risk scenarios, such as neonates or prolonged procedures, rather than universal use.

Induction Agents

Induction agents in rapid sequence induction (RSI) are sedative-hypnotic medications administered to rapidly achieve and , facilitating safe endotracheal while minimizing the risk of . These agents are selected based on hemodynamics, underlying conditions, and procedural needs, with a focus on rapid onset (typically within 30-60 seconds) and short duration to allow quick recovery if intubation fails. Common choices include , , and , each with distinct pharmacokinetic profiles that influence their use in emergency settings. Etomidate, dosed at 0.3 mg/kg intravenously, is the preferred induction agent for hemodynamically unstable patients due to its minimal effects on cardiovascular stability, preserving and through lack of significant or myocardial depression. It provides rapid onset and short duration (3-5 minutes), making it ideal for RSI in or scenarios. However, concerns exist regarding transient adrenal suppression from inhibition of 11β-hydroxylase, which may be problematic in septic or critically ill patients, though clinical guidelines suggest no increased mortality compared to alternatives. In obese patients, dosing is typically based on total body weight (TBW) to ensure adequate induction, as per recent reviews. Propofol, administered at 1-2 mg/kg intravenously, offers rapid onset and profound with properties, but it is generally avoided in patients with or due to its dose-dependent and myocardial depression, which can exacerbate cardiovascular instability. It is suitable for hemodynamically stable patients and those with elevated , as it reduces cerebral blood flow and metabolic demand. For obese individuals, dosing is recommended based on ideal body weight (IBW) to prevent overdose and prolonged recovery, according to updated guidelines. No dose adjustments are required for renal failure, given its primary hepatic and extrahepatic clearance. Ketamine, given at 1-2 mg/kg intravenously, is particularly advantageous in patients or those with agitation, as it maintains airway reflexes, provides analgesia, and supports through sympathomimetic effects that increase and . Unlike other agents, it preserves respiratory drive initially and is bronchodilatory, benefiting patients with . In obese patients, ketamine is dosed using IBW to account for its distribution into lean tissue, avoiding excessive effects from fat mass. Renal impairment does not necessitate dosing changes, as ketamine undergoes hepatic metabolism with inactive metabolites excreted renally. Recent 2025 reviews emphasize these weight-based adjustments for special populations to optimize safety and efficacy in RSI.

Neuromuscular Blocking Agents

Neuromuscular blocking agents (NMBAs) are essential components of rapid sequence induction (RSI), providing rapid paralysis to facilitate endotracheal intubation by abolishing tone and preventing reflexes that could complicate . These agents are administered immediately following induction agents, with selection guided by the need for rapid onset, predictable duration, and patient-specific risk factors. In RSI, depolarizing and non-depolarizing NMBAs are primarily used, each with distinct pharmacokinetic profiles that influence their clinical application. Succinylcholine, a depolarizing NMBA, remains a cornerstone for RSI due to its exceptionally rapid onset and short duration of action. The standard dose is 1 to 1.5 mg/kg administered intravenously, achieving maximal within 45 to 60 seconds. Its involve rapid by plasma , resulting in a brief duration of 5 to 10 minutes, which allows for without reversal agents. However, succinylcholine carries significant risks, including due to potassium release from muscle cells, particularly in patients with burns, trauma, or neuromuscular diseases such as injuries. It is contraindicated in these conditions, as can lead to cardiac arrhythmias. Rocuronium, a non-depolarizing NMBA, serves as a primary alternative to succinylcholine in RSI, especially when contraindications to the depolarizing agent exist. For rapid sequence purposes, a dose of 1.2 mg/kg intravenously provides an onset of 45 to 60 seconds, comparable to succinylcholine but with greater variability. Its differ markedly, involving hepatic and renal , which prolongs the duration to 30 to 60 minutes, necessitating reversal agents like for expedited recovery. encapsulates rocuronium, enabling rapid reversal within minutes, which is advantageous in scenarios of difficult . The choice between succinylcholine and rocuronium depends on patient factors, with guidelines recommending avoidance of succinylcholine in cases of injuries, burns beyond 24 hours, or other risks to prevent life-threatening complications. Rocuronium is preferred in these situations for its safer side-effect profile, though its longer duration requires careful consideration in resource-limited settings. Both agents ensure optimal intubating conditions when dosed appropriately, but individualized selection optimizes safety and efficacy in .

Adjunct Medications

Adjunct medications in rapid sequence induction (RSI) encompass agents administered during or immediately after the procedure to address specific risks or enhance safety, such as reversal of paralysis, hemodynamic stabilization, or aspiration prophylaxis. These drugs are selected based on patient factors and procedural context to mitigate complications without interfering with core induction components. Sugammadex serves as a key reversal agent for rocuronium-induced neuromuscular blockade, particularly in failed intubation scenarios during RSI, enabling rapid restoration of spontaneous ventilation. The dosing range is 2 mg/kg for moderate blockade to 16 mg/kg for immediate reversal approximately 3 minutes post-rocuronium administration, with the higher dose recommended when urgent recovery is clinically necessary. This agent encapsulates rocuronium molecules, facilitating quick elimination and reducing the need for alternative reversal methods like neostigmine. Sugammadex integrates with neuromuscular blocking agents by providing a targeted antidote, allowing clinicians to use high-dose rocuronium confidently in RSI protocols. Vasopressors, such as , are utilized to counteract post-induction in hemodynamically unstable patients undergoing RSI, where induction agents may exacerbate cardiovascular instability. Administered as push-dose boluses (typically 50–100 mcg) or infusions, increases primarily by elevating preload through venoconstriction, with an onset of about 1 minute. Its alpha-1 adrenergic effects make it suitable for scenarios involving anesthesia-induced , though monitoring for is essential. In obstetric RSI, non-particulate antacids like 0.3 M (30 mL orally) are routinely given to neutralize gastric acidity and minimize the risk of acid aspiration syndrome during emergency cesarean deliveries. This prophylaxis is recommended immediately before due to its rapid onset and lack of , which could complicate if regurgitation occurs. The 2025 consensus statement on adult RSI and post-intubation care emphasizes structured protocols incorporating as an adjunct to maintain hemodynamic stability and provide light without significant respiratory depression immediately following . , dosed at 0.2–1.4 mcg/kg/hour infusion, is preferred over alternatives like in select cases for its properties, which help control and fluctuations post-RSI.

Procedure

Preparation and Positioning

Preparation for rapid sequence induction (RSI) begins with a systematic equipment checklist to ensure all necessary tools are readily available and functional, minimizing delays during the procedure. Essential items include a functioning laryngoscope with Macintosh or Miller blades, endotracheal tubes sized 7.0 to 8.0 mm for adults (7.0-7.5 mm for females and 7.5-8.0 mm for males), a bougie or stylet for difficult airways, a video laryngoscope as a option, Yankauer and tonsil-tip devices, a bag-valve-mask apparatus, and an end-tidal CO2 detector for tube placement confirmation. Additionally, the kit must be prepared and accessible as part of the failed airway . All equipment should be tested prior to initiation, including laryngoscope light functionality and endotracheal tube cuff inflation. Patient positioning is critical to align the oral, pharyngeal, and laryngeal axes for optimal glottic visualization and to enhance safety. The standard "sniffing position" involves flexion of the at the C6-C7 level and extension at the (C1-C2), which facilitates direct by straightening the airway. For obese patients or those with limited mobility, ramping—elevating the torso and head to achieve an "ear-to-sternal notch" alignment—is recommended to improve success rates and . A 25° to 30° head-up or ramped position is often employed in critically ill patients to reduce aspiration risk and support preoxygenation, though evidence on oxygenation benefits varies. Intravenous (IV) access should be secured with at least one large-bore (e.g., 18-gauge or larger) to allow rapid fluid and medication administration if needed. Continuous monitoring is established using (ECG), (SpO2), non-invasive (NIBP), and to track throughout the procedure. Backup plans, including algorithms for failed and surgical airway access like , must be reviewed and equipment positioned nearby to address anticipated or unanticipated difficulties. Clear delineation of team roles enhances efficiency and safety during RSI. The coordinates the process, assesses the airway, and performs ; a designated assistant prepares equipment and applies any necessary external maneuvers; and a third member manages monitoring and supports efforts if required. Pre-procedure briefings using checklists, such as the RSI setup sheet, ensure task allocation and communication, reducing errors in high-stakes environments.

Preoxygenation and Pretreatment

Preoxygenation is a critical initial step in rapid sequence induction (RSI), involving the administration of 100% oxygen through a tight-fitting face mask for 3-5 minutes to denitrogenate the lungs and create an oxygen reservoir in the , thereby extending the safe apnea period before desaturation occurs. This process aims to achieve an (SpO2) of 90-100%, with end-tidal oxygen concentrations ideally exceeding 90%, which delays the onset of during the apneic phase following induction. Inadequate preoxygenation can lead to rapid desaturation, particularly in patients with reduced oxygen reserves. Apneic oxygenation complements preoxygenation by providing supplemental oxygen via a at 15 L/min during the period of and apnea, which helps maintain oxygenation through passive and can significantly extend the safe apnea time in patients with normal . This reduces the incidence of desaturation below 90% during RSI in emergency settings, though its benefits are less pronounced in critically ill patients with conditions like or lung injury. Pretreatment drugs, such as lidocaine (1.5 mg/kg intravenously) or fentanyl (2-3 mcg/kg intravenously), are administered 2-3 minutes prior to induction to attenuate sympathetic responses, including hypertension and tachycardia, thereby blunting the physiologic stress of laryngoscopy and reducing intracranial pressure elevations in susceptible patients. These agents are timed to achieve peak effect before the primary induction sequence, minimizing hemodynamic perturbations without significantly delaying the procedure. In critically ill adults, the Society of Critical Care Medicine (SCCM) 2023 guidelines emphasize vigilant monitoring for desaturation risks during RSI, recommending strategies like high-flow nasal oxygen or noninvasive for patients with severe (PaO2/FiO2 <150 mmHg) to help prevent desaturation. Continuous and clinical assessment are essential to identify and mitigate rapid oxygen reserve depletion in this population.

Induction and Paralysis

The and phase of rapid sequence (RSI) involves the swift intravenous delivery of an agent to render the patient unconscious, immediately followed by a neuromuscular blocking agent to achieve , with no intervening bag-mask to minimize risk. This sequence ensures optimal intubating conditions by rapidly suppressing airway reflexes and facilitating . Common agents include at 0.3 mg/kg, while paralytics such as succinylcholine at 1-1.5 mg/kg are administered without pause after confirming loss of consciousness. Following administration of the induction agent, the provider awaits clinical signs of , such as the absence of eyelash reflex or response to verbal stimuli, typically within 30-60 seconds depending on the agent used. The paralytic is then given, and onset is confirmed by observation of fasciculations (with depolarizing agents like succinylcholine) or relaxation, after which proceeds once is evident, generally 45-60 seconds post-paralytic. This timing optimizes conditions while avoiding premature attempts that could provoke complications. Continuous hemodynamic monitoring is critical during this phase, utilizing noninvasive , , and to identify instability such as or desaturation, which can arise from induction agents' vasodilatory effects or the patient's underlying condition. Prompt , including vasopressors or fluids, may be required to stabilize the patient before . In special populations like the elderly, dosing adjustments are essential due to heightened pharmacodynamic sensitivity and reduced physiologic reserve; for instance, induction agents like or are often reduced by 25-50% to mitigate risks of prolonged or respiratory depression. Similarly, non-depolarizing paralytics such as rocuronium may require lower doses (e.g., 0.6-1.0 mg/kg) to account for extended duration of action in older adults.

Intubation Technique

The intubation technique in rapid sequence induction (RSI) primarily involves to visualize the and facilitate endotracheal tube placement, performed immediately after the onset of to secure the airway. Direct is the traditional method, utilizing a curved Macintosh blade (sizes 3 or 4 for adults, inserted along the right side of the mouth) placed in the vallecula to lift the indirectly, or a straight Miller blade lifted directly on the , with the operator applying upward pressure at a 45-degree angle to expose the vocal cords. Video serves as an adjunct or alternative, particularly in anticipated difficult airways, by providing an enhanced glottic view through a camera-equipped blade, improving success rates when direct visualization fails. The Cormack-Lehane grading system assesses the laryngeal view during , with grade 1 indicating full visualization of the cords and higher grades signaling increasing difficulty. During , the Sellick maneuver—also known as cricoid pressure—is often applied by a separate trained assistant to compress the against the , reducing the risk of ; initial force is 10 N before , increasing to 30-40 N post-induction. Introduced by Sellick in 1961, this technique aims to occlude the but remains controversial due to inconsistent evidence of efficacy in preventing and potential complications such as laryngeal distortion that may hinder or . It is maintained from loss of consciousness until cuff inflation and tube position confirmation. Once the vocal cords are visualized, the endotracheal tube (typically 7.0-8.0 mm internal diameter for adults) is advanced through the cords using the right hand, with a stylet for guidance if needed; the tube is inserted to a depth of approximately 21 cm at the lips for women and 23 cm for men, followed by cuff inflation with 5-10 mL of air. Placement is confirmed using multiple methods: end-tidal CO2 (ETCO2) waveform capnography as the gold standard to detect exhaled CO2, visual assessment of symmetric chest rise, and auscultation for bilateral breath sounds, with chest radiography for final verification if required. In cases of failed intubation, protocols recommend limiting attempts to a maximum of three (plus one by a more experienced operator if available) to minimize risks of and , after which rescue oxygenation via a supraglottic airway device (e.g., laryngeal mask) is prioritized, escalating to a surgical front-of-neck access if ventilation fails. Tools like a bougie may assist during initial attempts by railroading the tube over it for indirect cord identification.

Post-Intubation Management

Following successful endotracheal intubation during rapid sequence induction (RSI), immediate post-intubation management focuses on stabilizing the patient through , analgesia, , hemodynamic support, and vigilant monitoring to prevent complications such as , , or instability. and analgesia are initiated promptly to blunt under paralysis and maintain comfort, typically with a infusion at 5-50 mcg/kg/min or boluses of 25-100 mcg every 15 minutes as needed, titrated to achieve a (RASS) score of -4. In patients with suspected , is increasingly recommended for its neuroprotective effects, including reduced neuronal mortality and hemodynamic stability, as supported by a 2025 emphasizing its role in preserving brain function post-injury. Mechanical ventilation is commenced with lung-protective settings to minimize , using an initial of 6-8 mL/kg predicted body weight and (PEEP) of 5-10 cmH2O, adjusted based on end-tidal CO2 and oxygenation goals. Hemodynamic support addresses common post-intubation by administering intravenous fluids or vasopressors such as (50-200 mcg every 1-2 minutes as needed) if falls below 80 mmHg, particularly in critically ill patients where preemptive optimization is key. Ongoing monitoring ensures tube security and physiological stability, including taping or tying the endotracheal tube in place, obtaining serial gases (ABGs) to confirm adequate , and performing a chest X-ray to verify placement with the tube tip 2-4 cm above the carina.

Complications and Risks

Immediate Complications

Rapid sequence induction (RSI) carries several immediate risks that can arise during or shortly after the procedure, primarily due to the urgency of in patients with compromised . These complications, while mitigated by standardized techniques, underscore the need for vigilant monitoring and preparedness for rescue interventions. remains a primary concern despite RSI's design to minimize it through rapid airway securing and . In settings, the incidence of during RSI varies widely, reported from 0% to as high as 22% across studies, though contemporary data suggest rates closer to 1-5% in non-elective cases with full precautions. This risk is heightened in patients with delayed gastric emptying or , potentially leading to or acute respiratory distress if gastric contents enter the lungs. Hypotension frequently occurs post-induction, particularly in critically ill adults, due to the vasodilatory and myocardial effects of agents compounded by positive . Incidences range from 20% to 52% in patients undergoing RSI, with up to 25% experiencing transient hemodynamic instability in settings; this can exacerbate organ hypoperfusion and is associated with increased mortality. Pretreatment with fluids or vasopressors may be considered to attenuate this, as briefly referenced in procedural preparation. Failed intubation, defined as inability to place the endotracheal tube after initial attempts, occurs in approximately 1-3% of RSI cases and can precipitate severe , esophageal , or airway trauma. Rates are higher in predicted difficult airways, reaching 1 in 50-100 procedures in critical care scenarios, necessitating immediate transition to alternative devices like supraglottic airways or surgical access to prevent desaturation below 90%. Right mainstem , where the endotracheal tube advances too far into the right , is a common malposition in intubations, with incidences of 4-7% reported in departmental series. This leads to unilateral ventilation, potential , and rapid from unventilated left lung collapse, often requiring prompt withdrawal and confirmation via or .

Delayed Complications

Delayed complications of rapid sequence induction (RSI) typically emerge hours to days following the procedure and are often linked to the subsequent need for and pharmacologic interventions. These include infections, persistent neuromuscular effects, ventilation-related injuries, and psychological sequelae, which can prolong stays and affect recovery. While immediate risks during RSI are well-documented, delayed issues arise primarily from intubation-related interventions and patient vulnerability in critical care settings. Ventilator-associated pneumonia (VAP) represents a significant delayed after RSI, stemming from potential of gastric contents during or of the endotracheal tube in mechanically ventilated patients. In settings, develops in approximately 13.4% of patients post-RSI, with witnessed occurring in 9.7% of cases and contributing to delayed pulmonary infections. factors include male gender (adjusted 7.29) and diabetes mellitus (adjusted 3.76), as these patients often present with full stomachs, increasing regurgitation likelihood. Diagnosis may be delayed beyond 48 hours, sometimes misclassified as , with tracheal aspirate levels aiding detection in only 44.4% of confirmed cases. Overall, incidence in mechanically ventilated patients ranges from 9% to 27%, with the highest in the first 10 days post-. Prolonged neuromuscular weakness can occur after RSI when non-depolarizing agents like rocuronium or vecuronium are used without adequate reversal or monitoring, leading to extended in critically ill patients. This contributes to intensive care unit-acquired (), a involving generalized muscle dysfunction first noted in the 1970s among ventilated patients receiving neuromuscular blocking agents (NMBAs) alongside corticosteroids. Although short-term NMBA use (e.g., 48 hours) shows no increased ICU-AW risk in trials, evidence linking NMBAs directly to ICU-AW remains , with only 31% of observational studies supporting a causal . Barotrauma, involving alveolar rupture and extra-alveolar air leakage, is a delayed complication of initiated post-RSI, particularly in patients with underlying lung pathology. It manifests as , , or , with an overall incidence of about 3% in mechanically ventilated adults, though rates reach 5-10% in (ARDS) cases. High tidal volumes and plateau pressures exceeding 30 cm H₂O during ventilation exacerbate risk by causing overdistention, especially in heterogeneous lungs post-intubation. In (COPD) patients, incidence is around 2.9%, while chronic elevates it to 10%. Protective ventilation strategies have reduced historical rates from 40-60% in ARDS. Awareness with paralysis (AWP), where patients recall sensory perceptions during neuromuscular blockade, is a distressing delayed psychological complication following RSI, often uncovered days later during recovery. In cohorts, AWP occurs in 3.4% of mechanically ventilated patients post-RSI, rising to 3.9% among survivors, and is strongly associated with rocuronium use (92.3% of cases; adjusted 7.22). Affected individuals report intense fear, pain, and feelings of impending death, leading to higher perceived threat scores (15.6 vs. 7.7) and elevated (PTSD) risk. Long-term sequelae include anxiety, , and PTSD symptoms, underscoring AWP as a preventable "never event" with profound impacts.

Special Populations

Pediatric Patients

Rapid sequence induction (RSI) in pediatric patients requires modifications to account for children's distinct anatomical, physiological, and pharmacokinetic differences compared to adults, such as higher oxygen consumption rates, smaller airway structures, and greater susceptibility to hemodynamic instability. These adaptations aim to minimize risks like rapid desaturation and while ensuring effective airway securing in emergencies like or . Guidelines emphasize weight-based dosing, precise positioning, and vigilant monitoring to optimize outcomes. Dosing adjustments for induction agents and paralytics in pediatric RSI are scaled by body weight to achieve rapid onset without excessive cardiovascular depression. , a commonly used induction agent, is dosed at 0.2-0.3 mg/kg intravenously, providing hemodynamic stability particularly beneficial in hypotensive children. Succinylcholine, the preferred paralytic for its fast onset (45-60 seconds), is administered at 2 mg/kg intravenously in most pediatric cases, though doses of 1-1.5 mg/kg may suffice in older children; however, it should be avoided in patients at risk for , such as those with burns beyond 24 hours, neuromuscular disorders, or renal failure, due to potential potassium release leading to cardiac arrhythmias. Rocuronium serves as an alternative paralytic at 1-1.2 mg/kg when succinylcholine is contraindicated, offering a longer duration but reversible with if needed. Pediatric airway anatomy poses unique challenges during RSI, including a relatively larger occiput in infants and young children that causes flexion of the neck and misalignment of the oral, pharyngeal, and tracheal axes. To correct this, a towel roll or padding is placed under the shoulders to achieve the "sniffing position," aligning the airway for better laryngoscopic visualization. Endotracheal tube selection includes both cuffed and uncuffed options; uncuffed tubes are sized as (age in years/4 + 4) for children 2-8 years (typically 4.0-6.0 internal diameter), while cuffed tubes use (age/4 + 3.5); prepare a half-size smaller tube as backup to avoid traumatic insertion. Cuffed tubes are often preferred in modern practice for improved seal and fewer reintubations. Video laryngoscopy is often recommended to improve first-pass success rates given these anatomical variances. Preoxygenation in pediatric RSI is limited to 1-2 minutes of breathing with 100% oxygen via a or bag-valve-mask, as children have higher baseline oxygen consumption (6-8 mL/kg/min in infants versus 3-4 mL/kg/min in adults), leading to faster denitrogenation but also quicker desaturation during apnea. This shorter duration suffices to achieve end-tidal oxygen fractions near 90%, but apneic oxygenation via (5-15 L/min) is advised concurrently to extend safe apnea time, especially in infants where desaturation can occur within 30-45 seconds. Special risks in pediatric RSI include drug-induced , particularly from succinylcholine or during , which is more prevalent in infants under 1 year due to immature autonomic responses and vagal stimulation. Atropine may be considered as pretreatment (0.02 mg/kg IV) in infants during emergency intubation to prevent , particularly with succinylcholine, per guidelines, though routine use lacks strong evidence. Monitoring with and is essential to detect and address these risks promptly.

Obstetric Patients

Rapid sequence induction (RSI) in obstetric patients must account for pregnancy-related physiological changes, including aortocaval by the gravid and heightened risk of due to delayed gastric emptying and reduced lower esophageal . To mitigate aortocaval , which can impair venous return and , patients are positioned in a left lateral tilt of 15 to 30 degrees during induction and ; this maneuver optimizes , reduces gastroesophageal reflux, and maintains hemodynamic stability. The emphasis on rapid sequence techniques is particularly critical in obstetric RSI to minimize the interval between induction and airway securing, given the elevated risk from progesterone-mediated gastrointestinal delays. prophylaxis, such as H2-receptor antagonists and , is administered pre-induction, and cricoid pressure is applied to further reduce regurgitation potential. For induction agents, thiopental remains a traditional choice when available due to its rapid onset and placental transfer profile, though (1.5 mg/kg) is preferred in hemodynamically unstable patients for its sympathomimetic effects that support without significant fetal depression. Rocuronium (1.0–1.2 mg/kg) serves as an alternative to succinylcholine for , enabling faster reversal if needed. Failed intubation occurs at a higher incidence in obstetric RSI, approximately 1 in 300 cases, often linked to airway edema, reduced oxygen reserves, and procedural challenges under urgency. Preparation for this includes immediate availability of backup devices like videolaryngoscopes and early readiness for surgical airway intervention, such as cricothyroidotomy, to avert maternal and fetal compromise. In postpartum patients undergoing RSI, such as for hysterectomy due to hemorrhage, rapid reversal of neuromuscular blockade is prioritized to facilitate and mitigate risks of atony, the leading cause of ; enables prompt antagonism of rocuronium, allowing quicker recovery compared to neostigmine for succinylcholine. Extubation is performed in a head-up or left lateral position to further minimize during .

Critically Ill Adults

In critically ill adults, particularly those with multi-organ dysfunction in the (ICU), rapid sequence induction (RSI) requires tailored modifications to mitigate risks of hemodynamic instability and procedural failure. These patients often present with , , or , where standard RSI protocols may exacerbate or desaturation. A 2025 systematic review and reported first-attempt failure rates of 20-30% in critically ill patients, significantly higher than in elective settings, underscoring the need for optimized pre-intubation preparation and agent selection. Hemodynamic optimization is paramount prior to RSI in these patients to counteract the vasodilatory effects of induction agents and positive pressure ventilation. Strategies include fluid preloading with 500-1000 mL of crystalloid to expand intravascular volume, alongside prophylactic vasopressor administration such as boluses in individuals. remains the preferred induction agent over due to its minimal impact on cardiovascular stability, with studies showing reduces post-intubation risk by preserving sympathetic tone in hemodynamically unstable patients. The Society of Critical Care Medicine (SCCM) 2023 RSI guidelines conditionally recommend or for induction in such cases, noting no significant mortality difference but emphasizing 's reliability in . Dosing adjustments are essential owing to altered from -induced or hepatic , which prolong drug half-lives and increase toxicity risk. Induction agents like or should be reduced to 50-75% of standard doses (e.g., 1-1.5 mg/kg instead of 2 mg/kg) in patients with or to avoid excessive and respiratory depression. The SCCM guidelines advocate individualized dosing based on organ function, with favored at lower doses (1-2 mg/kg) for its bronchodilatory effects and reduced incidence in . Post-intubation management in critically ill adults prioritizes analgesia-first approaches to prevent and ventilator dyssynchrony, with emphasized for its sympathomimetic properties in agitated patients. The SCCM 2023 RSI guidelines, aligned with the 2018 Pain, Agitation/, Delirium, Immobility, and Sleep Disruption (PADIS) recommendations, suggest - combinations for post-intubation , using low-dose (0.5 mg/kg bolus followed by 0.2-0.5 mg/kg/h infusion) as an adjunct and (0.2-0.7 μg/kg/h) for light without respiratory depression. This combo reduces risk and supports hemodynamic stability in multi-organ failure.

Historical Development

Origins

The origins of rapid sequence induction (RSI) in stem from early 20th-century concerns over , a potentially fatal complication during . In 1946, obstetrician Curtis L. Mendelson first described what became known as Mendelson's syndrome, a form of resulting from the of acidic gastric contents into the lungs, based on his analysis of 66 cases among pregnant women under general . This work underscored the heightened risk in due to delayed gastric emptying, reduced lower esophageal sphincter tone, and the , prompting innovations to secure the airway swiftly and securely. A key advancement influencing RSI came in 1961, when anesthesiologist Brian A. Sellick published his seminal paper on cricoid pressure—a manual compression of the to occlude the and prevent passive regurgitation of gastric contents during induction. Sellick's , demonstrated in studies and a small clinical series, was designed specifically to address regurgitation risks in patients with full stomachs, laying the groundwork for integrating protective maneuvers into protocols. RSI as a cohesive method was formalized in 1970 by anesthesiologists William J. Stept and , who described it as a "rapid induction-intubation" sequence to minimize during for patients at risk, such as those undergoing emergency surgery. Initially applied in elective and semi-elective cases with potential for gastric content reflux, the technique gained traction in to avert Mendelson's , where rapid airway control was critical for peripartum patients. Prior to the 1980s, RSI predominantly involved intravenous thiopental for rapid hypnosis and suxamethonium (succinylcholine) for quick-onset paralysis, combined with Sellick's cricoid pressure to facilitate immediate endotracheal without bag-mask .

Evolution and Modern Updates

During the 1990s, rapid sequence induction (RSI) transitioned from its primary use in operating rooms to widespread adoption in emergency departments (EDs) and prehospital environments, particularly for managing trauma patients requiring urgent airway control. This shift was driven by the need for rapid, reliable intubation in unstable settings, with early ED studies demonstrating high success rates and low complication profiles in diverse patient populations. Concurrently, rocuronium emerged as a key alternative to succinylcholine, introduced in 1994, offering comparable onset times for paralysis while avoiding the hyperkalemia and malignant hyperthermia risks associated with succinylcholine, thus broadening RSI applicability in emergency trauma care. In the 2000s, advancements in visualization technology further refined RSI techniques in emergency settings. Video laryngoscopy, exemplified by the GlideScope introduced around 2003, became integrated into RSI protocols, providing superior glottic views and significantly reducing first-attempt intubation failures compared to direct laryngoscopy, especially in trauma and difficult airways. This adoption improved overall success rates in EDs, with studies reporting up to 20-30% higher first-pass intubation in high-risk cases. Additionally, ketamine experienced a resurgence during this period for hemodynamically unstable patients, favored for its sympathomimetic effects that maintain blood pressure and cardiac output during induction, supplanting etomidate in scenarios where adrenal suppression was a concern. The have seen RSI evolve with a stronger emphasis on supportive measures informed by critical care evidence. The Society of Critical Care Medicine's 2023 clinical practice guidelines for RSI in critically ill adults suggest preoxygenation with high-flow nasal oxygen when is expected to be challenging, alongside evidence from observational studies indicating faster provision of post-intubation analgosedation when succinylcholine is used compared to rocuronium, to address risks of inadequate . These updates prioritize hemodynamic stability and oxygenation strategies, reflecting conditional recommendations based on low-quality evidence from observational studies showing reduced incidence. Evidence-based refinements have also led to decreased reliance on cricoid pressure during RSI, as multiple trials demonstrated its inefficacy in preventing without improving outcomes. Key studies, including the 2019 IRIS randomized controlled trial, found no reduction in regurgitation or rates with cricoid pressure application, while highlighting risks such as airway obstruction in up to 56% of cases at standard forces. Earlier investigations confirmed worsened laryngoscopic views and vocal cord closure in 43-50% of applications, prompting major guidelines from the Scandinavian Society (2010), German Society (2015), and (2015) to abandon routine use. This evidence-driven change has streamlined RSI protocols, focusing resources on more effective prevention strategies like preoxygenation. As of 2025, the Difficult Airway Society guidelines continue to recommend cricoid pressure in high-risk patients, with force adjustments (10 N pre-induction, 30 N post), while noting evidence gaps and training needs.

Controversies and Guidelines

Key Controversies

One of the primary controversies surrounding rapid sequence induction (RSI) centers on the application of cricoid pressure, also known as the Sellick maneuver, which aims to occlude the against the to prevent passive regurgitation and of gastric contents. While traditionally a cornerstone of RSI, evidence regarding its efficacy remains mixed, with multiple studies and systematic reviews indicating that it does not reliably reduce the incidence of during emergency . Furthermore, cricoid pressure has been associated with potential harms, including distortion of airway anatomy that can worsen the laryngoscopic view, impede first-pass success, and even cause complications such as vocal cord closure or esophageal perforation in rare cases. In response to this conflicting data, the 2025 Difficult Airway Society () guidelines advocate for selective rather than routine use of cricoid pressure, recommending it only in scenarios where risk is deemed high and its application can be performed correctly by trained personnel, emphasizing individualized assessment to balance benefits against risks. The selection of neuromuscular blocking agents in RSI—specifically succinylcholine versus rocuronium—continues to spark debate due to trade-offs in onset, , safety, and reversibility. Succinylcholine offers rapid onset and superior intubating conditions in most patients, achieving excellent laryngeal exposure more frequently than rocuronium at standard doses, but it poses significant risks of , particularly in patients with burns, neuromuscular disorders, or prolonged , potentially leading to life-threatening cardiac arrhythmias. In contrast, rocuronium provides a non-depolarizing alternative with comparable onset when dosed at 1.2 mg/kg, avoiding entirely, though its longer duration of action (typically 30-60 minutes without reversal) has historically raised concerns about prolonged apnea in hemodynamically unstable or critically ill patients. The advent of , a selective reversal agent, has largely addressed these duration concerns by enabling rapid reversal of rocuronium-induced blockade within 2-3 minutes, often faster than succinylcholine's time of 5-10 minutes, thereby shifting preferences toward rocuronium in many emergency settings where reversal capability is available. In patients with predicted difficult airways, the choice between RSI and awake techniques remains a contentious issue, particularly the decision to administer paralytics early in RSI, which eliminates spontaneous and may complicate rescue maneuvers if fails. Awake techniques, such as topical with and fiberoptic guidance, preserve respiratory drive and allow for ongoing assessment of airway patency, potentially reducing risks in anatomically challenging cases like or severe , but they can prolong the procedure and require patient cooperation, which may not be feasible in agitated or hypoxic individuals. Proponents of modified RSI argue for its speed in emergencies to secure the airway definitively, while critics highlight the debate over delaying to permit a of awake approaches or delayed sequence , weighing the urgency of intervention against the heightened failure risks (up to 10-20% in predicted difficult airways) associated with full . This tension underscores broader discussions on airway algorithms that prioritize pre- prediction tools and plans to mitigate "can't , can't " scenarios. Although RSI was developed primarily to minimize aspiration risk during emergency intubation by combining preoxygenation, rapid medication administration, and immediate without bag-mask , its actual impact on aspiration incidence in () settings is debated, with evidence suggesting it may not confer the protective effect once assumed. Multiple studies and reviews have found no significant reduction in aspiration rates with RSI compared to non-RSI techniques, attributing this to factors like incomplete gastric emptying, high intra-abdominal pressure in critically ill patients, or procedural delays in chaotic environments. In cohorts, aspiration occurs in approximately 13% of RSI attempts, often linked to unrecognized full stomachs or failed first-pass intubations, challenging the notion of RSI as a near-foolproof aspiration prevention strategy and prompting calls for like gastric or enhanced preoxygenation protocols.

Current Evidence and Guidelines

The Society of Critical Care Medicine (SCCM) 2023 clinical practice guidelines strongly recommend the use of rapid sequence (RSI) in critically ill adult patients at risk of , emphasizing the combination of a sedative-hypnotic agent and a neuromuscular blocking agent to optimize conditions and minimize regurgitation risks. These guidelines highlight and as preferred induction agents due to their hemodynamic stability, with conditional suggestions indicating no significant differences between and alternatives like in terms of mortality, incidence, or vasopressor requirements based on moderate-quality evidence. A 2025 systematic review of RSI protocols in settings found that protocolized approaches, including checklists, standardized operating procedures, and operator training, significantly enhance first-pass success rates in the , with mean improvements ranging from 10.6% to 23.0% across included studies—translating to an overall ED-specific gain of approximately 12% when compared to non-protocolized intubations. The Difficult Airway Society (DAS) 2025 guidelines for unanticipated difficult advocate limiting intubation attempts to a maximum of three plus one final attempt by a more experienced colleague (3+1), after which failed intubation should be declared to prioritize oxygenation strategies. These guidelines place strong emphasis on as a first-line or aid during RSI to improve glottic visualization and success rates, particularly in contexts. Regarding post-intubation management, the SCCM 2025 guidelines on , , , , and disruption in critically ill adults recommend multimodal sedation protocols—combining analgesics, light sedatives, and non-pharmacologic interventions—over deep sedation to reduce incidence in mechanically ventilated patients following RSI, supported by evidence from prospective cohorts showing decreased days with electroencephalography-guided approaches.

References

  1. [1]
  2. [2]
    Rapid Sequence Intubation - Medscape Reference
    Apr 7, 2020 · RSI is the preferred method of endotracheal tube intubation (ETTI) in the emergency department (ED). This is because it results in rapid unconsciousness ( ...Background · Indications · Contraindications · Best Practices<|control11|><|separator|>
  3. [3]
    Rapid Sequence Induction and Cricoid Pressure - OpenAnesthesia
    Jan 21, 2025 · It involves administering a rapid-acting sedative and neuromuscular blocking agent, followed by endotracheal intubation.
  4. [4]
    Tracheal Rapid Sequence Intubation - StatPearls - NCBI Bookshelf
    Rapid sequence intubation (RSI) is a technique used when rapid control of the airway is needed as a precaution for patients who may have risks of pulmonary ...Missing: authoritative | Show results with:authoritative
  5. [5]
    Rapid Sequence Intubation (RSI) - LITFL
    Rapid sequence intubation (RSI) is an airway management technique that produces inducing immediate unresponsiveness (induction agent) and muscular relaxation ( ...
  6. [6]
    Rapid sequence induction: where did the consensus go?
    May 13, 2021 · Rapid Sequence Induction (RSI) was introduced to minimise the risk of aspiration of gastric contents during emergency tracheal intubation.Missing: definition | Show results with:definition
  7. [7]
  8. [8]
    Society of Critical Care Medicine Clinical Practice Guidelines for ...
    - Complete Recommendations and Suggestions for Clinical Practice Guidelines for Rapid Sequence Intubation in the Critically Ill Adult Patient. Swipe left or ...Missing: indications | Show results with:indications
  9. [9]
    Rapid Sequence Induction - an overview | ScienceDirect Topics
    Patients with full stomachs are at risk; other risk factors include pregnancy, diabetes, pain, opioid analgesics, recent traumatic injury, intoxication, and ...
  10. [10]
    Chapter 10. Rapid Sequence Induction - AccessEmergency Medicine
    The rationale behind RSI is to create an environment in which the trachea can be intubated as quickly and with as little difficulty as possible.Missing: core | Show results with:core
  11. [11]
    Guidelines for Rapid Sequence Intubation in the Critically Ill Adult ...
    Sep 12, 2023 · We suggest use of the head and torso inclined (semi-Fowler) position during RSI. · We suggest preoxygenation with HFNO when laryngoscopy is ...Missing: core | Show results with:core
  12. [12]
    Society of Critical Care Medicine Clinical Practice Guidelines for ...
    Society of Critical Care Medicine Clinical Practice Guidelines for Rapid Sequence Intubation in the Critically Ill Adult Patient. Crit Care Med. 2023 Oct 1; ...
  13. [13]
  14. [14]
    Rapid Sequence Intubation Pharmacology - ACEP Now
    Sep 1, 2010 · When used as a pretreatment agent, lidocaine is dosed at 1.5 mg/kg intravenously, and the duration of action is approximately 10-20 minutes.
  15. [15]
    Pretreatment drugs for RSI - LITFL
    Jul 2, 2024 · Traditionally there are four options for pretreatment for Rapid Sequence Intubation (RSI): atropine, lidocaine, fentanyl, ...
  16. [16]
    Prophylactic lidocaine use preintubation: a review - PubMed
    A dose of prophylactic lidocaine of 1.5 mg/kg given intravenously 3 minutes before intubation is optimal.
  17. [17]
    Rapid Sequence Intubation in Traumatic Brain-injured Adults - PMC
    Apr 25, 2018 · Lidocaine has historically been used as a pretreatment in TBI as it was believed to lessen the sympathetic stimulation associated with RSI.
  18. [18]
    Initial Diagnosis and Management of Acutely Elevated Intracranial ...
    Since then, 2 systematic reviews of TBI patients undergoing RSI found no benefit of IV lidocaine for decreasing elevated ICP. A separate systematic ...
  19. [19]
    In patients with head injury undergoing rapid sequence intubation ...
    There is currently no evidence to support the use of intravenous lidocaine as a pretreatment for RSI in patients with head injury and its use should only occur ...
  20. [20]
    Rapid sequence induction and intubation - PMC - PubMed Central
    Fentanyl, 1–3 μg kg−1, To attenuate the sympathetic response to laryngoscopy. Consider in patients with raised intracranial pressure, malignant hypertension ...
  21. [21]
    Association Between Fentanyl Use and Post-Intubation Mean ... - NIH
    Nov 7, 2024 · The purpose of fentanyl is to blunt the sympathetic surge induced by laryngoscopy; thus, dosing should be decided with caution. While lower ...
  22. [22]
    Tracheal Intubation Medications - StatPearls - NCBI Bookshelf - NIH
    Fentanyl is a synthetic opioid that binds to opiate receptors resulting in decreased pain. Endotracheal intubation results in sympathetic nervous stimulation ...
  23. [23]
    Atropine therapy versus no atropine therapy for the prevention of ...
    Atropine sulfate, given for the indication of premedication for intubation, is typically given intravenously in a dose of 0.02 mg/kg per dose to a maximum of ...
  24. [24]
    Atropine: Re‐evaluating its use during paediatric RSI - PMC - NIH
    It is concluded that there is evidence that the routine use of atropine is does not reduce the incidence of bradycardia during RSI in paediatric patients.
  25. [25]
    Pharmacology for Rapid Sequence Intubation (RSI) Airway ... - JOMI
    Jul 23, 2024 · Trauma patients may require intubation for a number of reasons (Table 1) including, but not limited to, hypoxia, hypoventilation, potential for ...Missing: epilepticus | Show results with:epilepticus
  26. [26]
    Neuromuscular blockade management in the critically Ill patient
    May 24, 2020 · While succinylcholine provides rapid and reliable neuromuscular blockade, higher doses of rocuronium (1.2 mg/kg or 4× the effective dose that ...
  27. [27]
    Neuromuscular Blocking Agents - StatPearls - NCBI Bookshelf - NIH
    Jun 8, 2024 · Neuromuscular blocking agents (NMBAs) are most effective when administered intravenously or intramuscularly. They are poorly absorbed if ...
  28. [28]
    Succinylcholine versus rocuronium for rapid sequence intubation in ...
    Rocuronium has the most rapid onset of the currently available non-depolarizing neuromuscular blocking drugs. As the only contraindication to rocuronium is the ...
  29. [29]
    Development of a standard operating procedure and checklist for ...
    Sep 11, 2014 · The SOP consists of a RSI equipment set-up sheet, pre-RSI checklist and failed airway algorithm. The SOP should improve RSI preparation, crew resource ...
  30. [30]
    Rapid sequence induction: where did the consensus go? - PMC - NIH
    May 13, 2021 · Rapid Sequence Induction (RSI) was introduced to minimise the risk of aspiration of gastric contents during emergency tracheal intubation.
  31. [31]
    Is adequate preoxygenation about more than just 3 minutes? - NIH
    Common practice in emergency settings to achieve adequate preoxygenation is to ensure SpO 2 levels > 93% for at least 3 minutes.
  32. [32]
    Nasal Cannula Apneic Oxygenation Prevents Desaturation During ...
    Feb 22, 2018 · The use of nasal oxygen during pre-oxygenation and continued during apnea can prevent hypoxia before and during intubation, extending safe apnea time, and ...
  33. [33]
    Use of lidocaine and fentanyl premedication for neuroprotective ...
    The purpose of this study was to determine the frequency with which neuroprotective agents were used for neuroprotective RSI in the emergency department.
  34. [34]
    Society of Critical Care Medicine Clinical Practice Guidelines
    A common strategy for emergency airway management is RSI, which is defined as the administration of a sedative-hypnotic agent and a fast-acting neuromuscular- ...Missing: indications | Show results with:indications<|control11|><|separator|>
  35. [35]
    Intubation Endotracheal Tube Medications - StatPearls - NCBI - NIH
    Common sedative agents used during rapid sequence intubation include etomidate, ketamine, and propofol. Commonly used neuromuscular blocking agents include ...
  36. [36]
    08. Rapid Sequence Intubation - UCSF Hospitalist Handbook
    Precautions. Anatomic assessment that predicts difficult intubation or impossible rescue oxygenation is a relative contraindication to RSI and alternative ...
  37. [37]
    Selection of Paralytic and Induction Agents in RSI - ICU Reach
    Oct 25, 2022 · Finally, etomidate is the preferred agent in geriatric patients and the dose should be reduced to half in fragile or hypotensive patients. Agent.
  38. [38]
    Age-Specific Pharmacology of Neuromuscular Blocking Agents - NIH
    The intubation dose of rocuronium is typically 0.6 mg/kg. In rapid-sequence intubation, 1.0–1.2 mg/kg enables intubation within 60 seconds. Boluses of 0.1–0.2 ...
  39. [39]
    [PDF] Age-Related Intravenous Induction Dosing In Patients Undergoing ...
    Induction dosing for midazolam can be up to 0.3 mg/kg in young healthy adults, however a reduction of at least 50% is recommended for patients over the age of ...
  40. [40]
    Endotracheal Intubation Techniques - StatPearls - NCBI Bookshelf
    Jul 10, 2023 · RSI is accomplished by using medications that have a quick onset and short duration of action.
  41. [41]
    Rapid-sequence intubation and cricoid pressure - PMC - NIH
    As a basis for discussion, it has been suggested that the algorithm of RSI consist of six primary steps: Pre-oxygenation, premedication, induction and muscle ...Missing: core | Show results with:core<|control11|><|separator|>
  42. [42]
    Difficult Airway Society 2015 guidelines for management of ...
    Nov 10, 2015 · These guidelines provide a strategy to manage unanticipated difficulty with tracheal intubation. They are founded on published evidence.
  43. [43]
    [PDF] Consensus Statement: ADULT Rapid Sequence Intubation and Post ...
    Jan 20, 2025 · RSI Guidelines should include assessments to help identify the possibility of a difficult intubation. The modified. LEON acronym is a ...
  44. [44]
    Role of dexmedetomidine in brain injury: a systematic review - PMC
    Sep 30, 2025 · Dexmedetomidine has demonstrated potent neuroprotective benefits, including preserving hemodynamic stability, lowering neuronal mortality, ...
  45. [45]
    Initial mechanical ventilation settings - WikEM
    Jan 5, 2022 · Mode. Volume-assist control · Tidal Volume. Start 6-8cc/kg predicted body weight · Inspiratory Flow Rate (comfort). More comfortable if higher ...
  46. [46]
    Overview of Mechanical Ventilation - Critical Care Medicine
    A low tidal volume of 6 to 8 mL/kg ideal body weight (IBW) is recommended initially for patients with acute respiratory distress syndrome (ARDS—see sidebar ...Respiratory Mechanics · Components Of Airway... · Ventilator SettingsMissing: RSI | Show results with:RSI
  47. [47]
    EMCrit 84 - The Post-Intubation Package
    Oct 16, 2012 · When getting an x-ray make sure the head is in a neutral vertical position (remember the tube follows the nose, nose down-tube deep). Bonus: ...
  48. [48]
    [PDF] Rapid Sequence Intubation (RSI)
    - Consider insertion of arterial cannula for Invasive BP monitoring if safe to delay intubation ... ▫ Chest x-ray. • Secure ETT with cotton ribbon tie.
  49. [49]
    Post-intubation management (Chapter 10) - Emergency Airway ...
    Tube position confirmed by end tidal CO 2 monitoring and chest X-ray. Patient paralyzed, sedated and ventilated. Adequate gas exchange confirmed by ABG.<|control11|><|separator|>
  50. [50]
    Delayed Complications of Emergency Airway Management - NIH
    Immediate complications that have been consistently identified include esophageal intubation, mainstem bronchus intubation, aspiration, oxygen desaturation and ...
  51. [51]
    Aspiration Pneumonia after Rapid Sequence Intubation - NIH
    The recently published OcEAN study also reported a 42.6% (55 of 129) incidence of complications during airway management in ED. Hypotension (20.2%), ...
  52. [52]
    Ventilator-Associated Pneumonia - Pulmonary Disorders
    The highest risk of ventilator-associated pneumonia occurs during the first 10 days after intubation. Ventilator-associated pneumonia occurs in 9 to 27% of ...
  53. [53]
    Neuromuscular Blockade and Skeletal Muscle Weakness in ...
    Jul 24, 2011 · Neuromuscular blocking agents (NMBAs) are commonly administered to critically ill patients to induce muscular paresis. Extended administration of NMBAs is ...Missing: RSI | Show results with:RSI
  54. [54]
    Barotrauma and Mechanical Ventilation - Medscape Reference
    Feb 1, 2024 · Barotrauma is a well-recognized complication of mechanical ventilation. Although most frequently encountered in patients with the acute ...
  55. [55]
    Awareness with paralysis among critically ill emergency department ...
    In critically ill mechanically ventilated patients, awareness with recall of paralysis can cause intense fear, pain, feelings of impending death, and thoughts ...
  56. [56]
    [PDF] A Modern and Practical Review of Rapid-Sequence Intubation in ...
    The risks associated with placement of the NG/OG tube include interruption of preoxygenation; induction of vomiting, with the potential for aspiration, if the ...
  57. [57]
    Etomidate - StatPearls - NCBI Bookshelf - NIH
    The dose for induction of anesthesia in adult and pediatric patients above the age of 10 varies between 0.2 and 0.6 mg/kg of body weight. Use is not ...
  58. [58]
    [PDF] PEDIATRIC RSI DRUGS
    *All emergency drugs (i.e., epinephrine, atropine, vasopressors) should be immediately available during RSI. * See code sheets for Braslow tape, mL dosing ...
  59. [59]
    Paediatric Rapid Sequence Intubation SID - LITFL
    Nov 3, 2020 · RSI is used to secure the airway quickly with an endotracheal tube and to prevent chance of regurgitation and aspiration; the basic approach ...Missing: positioning | Show results with:positioning
  60. [60]
    Pediatric Endotracheal Tube (ETT) Size - MDCalc
    Tidal volume in pediatrics is often set 6-8mL/kg · Respiratory rate is often set 25-40 breaths / minute · FiO2 is often started at 1.0 (100%).Missing: RSI | Show results with:RSI<|separator|>
  61. [61]
    Place of rapid sequence induction in paediatric anaesthesia
    Time to complete preoxygenation is theoretically shorter in children because of a smaller lung volume and an increased respiratory rate, creating a faster ...
  62. [62]
    Apnoeic oxygenation in paediatric anaesthesia: a narrative review
    Jun 27, 2020 · In 2015, a seminal paper by Patel and Nouraei demonstrated adequate oxygenation for periods of up to 65 min with the use of high-flow nasal ...
  63. [63]
    Part 8: Pediatric Advanced Life Support: 2025 American Heart ...
    Oct 22, 2025 · These guidelines are intended to be a resource for health care professionals to identify and treat infants and children up to 18 years of age ( ...
  64. [64]
    Incidence of Bradycardia and the Use of Atropine in Pediatric Rapid ...
    Feb 1, 2022 · Atropine has historically been used in the pediatric population as RSI premedication to prevent bradycardia, especially when using ...Missing: dose | Show results with:dose
  65. [65]
    Obstetric Anaesthetists' Association and Difficult Airway Society ...
    Oct 8, 2015 · In the past, patients who had a rapid sequence induction underwent extubation in the left lateral/head-down position.
  66. [66]
    Airway management and pulmonary aspiration during surgical ... - NIH
    May 3, 2024 · Pregnancy is associated with an increased risk of pulmonary aspiration during general anaesthesia, but the incidence of this complication is not well defined.
  67. [67]
    Anaesthesia for non-obstetric surgery during pregnancy
    Jan 14, 2023 · Beyond 18–20 weeks' gestation, patients should be positioned with a 15–30° left lateral tilt when supine to reduce aortocaval compression.
  68. [68]
    Thiopental-rocuronium versus ketamine-rocuronium for rapid ...
    We concluded that ketamine 1.5 mg/kg followed by rocuronium 0.6 mg/kg may be suitable for rapid-sequence induction of anesthesia in parturients undergoing ...
  69. [69]
    Difficult and failed intubation management in obstetrics - ScienceDirect
    While deaths from failed intubation have declined significantly over 30 years, the incidence of failed intubation remains fairly constant at 1:300, with the ...
  70. [70]
    a systematic review and meta-analysis of randomized controlled trials
    Apr 15, 2025 · However, the first intubation in critically ill patients still has a high failure rate of about 20–30% [3]. Video laryngoscope (VL) is equipped ...
  71. [71]
    Changes in hemodynamic parameters with the use of etomidate ...
    Mar 8, 2021 · Objectives: Etomidate is the sedative agent of choice during rapid sequence intubation (RSI) owing to its hemodynamic stability, rapid onset of ...<|separator|>
  72. [72]
    Etomidate Compared to Ketamine for Induction during Rapid ... - NIH
    The use of etomidate for induction during RSI is associated with a decreased risk of post-induction hypotension as compared to the use of ketamine.
  73. [73]
    Anesthesia for Patients With Liver Disease - PMC - PubMed Central
    Therefore, dose of these drugs should be reduced. Among intravenous anesthetic agents, Propofol is the anesthetic drug of choice in patients with liver disease.
  74. [74]
    Guidelines for the Prevention and Management of Pain, Agitation ...
    Aug 21, 2018 · We suggest using low-dose ketamine (0.5 mg/kg IVP x 1 followed by 1-2 μg/kg/min infusion) as an adjunct to opioid therapy when seeking to reduce ...Missing: RSI | Show results with:RSI
  75. [75]
    The aspiration of stomach contents into the lungs during ... - PubMed
    The aspiration of stomach contents into the lungs during obstetric anesthesia. ... 1946 Aug:52:191-205. doi: 10.1016/s0002-9378(16)39829-5. Author. C L MENDELSON.
  76. [76]
    Mendelson Syndrome - StatPearls - NCBI Bookshelf - NIH
    Due to high aspiration risk, pregnant women should undergo rapid sequence induction with cricoid pressure. Aspiration most commonly includes organisms from ...
  77. [77]
    Cricoid pressure to control regurgitation of stomach contents during ...
    Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia. Lancet. 1961 Aug 19;2(7199):404-6. doi: ...Missing: RSI | Show results with:RSI
  78. [78]
    Cricoid pressure: Where do we stand? - PMC - NIH
    In 1961, Sellick popularized the technique of cricoid pressure (CP) to prevent regurgitation of gastric contents during anesthesia induction.
  79. [79]
    Rapid induction-intubation for prevention of gastric-content aspiration
    Rapid induction-intubation for prevention of gastric-content aspiration. Anesth Analg. 1970 Jul-Aug;49(4):633-6. Authors. W J Stept, P Safar. PMID: 5534675.
  80. [80]
    Rapid sequence intubation in the emergency department
    This retrospective study was done to review our experience with RSI and assess the related morbidity and mortality. Two hundred and nineteen intubations were ...
  81. [81]
    Rapid sequence anesthesia induction for emergency intubation - LWW
    The purpose of this article is to describe the use of RSI in the airway management of ED patients. Nineteen pediatric patients requiring emergency intubation ...
  82. [82]
    Rocuronium and sugammadex in emergency medicine - PubMed
    In 1996, rocuronium was introduced, which was capable of immediately establishing good intubation conditions similar to succinylcholine. However, the median ...Missing: date | Show results with:date
  83. [83]
    The GlideScope Video Laryngoscope: A Narrative Review
    Since its introduction circa 2003, hundreds of studies have attested to its value in making clinical airway management easier and safer. This review will update ...
  84. [84]
    Video Laryngoscopy Is Associated With First-Pass Success in ...
    Aug 7, 2025 · Video laryngoscopy is associated with improved first‐pass intubation success compared with direct laryngoscopy in emergency department trauma ...
  85. [85]
    Ketamine's Versatility Makes it a Powerful Tool for EMS - JEMS
    Jan 31, 2017 · Interestingly, in the late 1990s and early 2000s, a resurgence of ... Clinical practice guideline for emergency department ketamine ...
  86. [86]
    [PDF] Society of Critical Care Medicine Clinical Practice Guidelines for ...
    TABLE 1. Complete Recommendations and Suggestions for Clinical Practice Guidelines for Rapid. Sequence Intubation in the Critically Ill Adult Patient.
  87. [87]
    Effect of Cricoid Pressure Compared With a Sham Procedure in the ...
    Oct 17, 2018 · This large, randomized double-blind trial in patients undergoing anesthesia with RSI failed to demonstrate the noninferiority (δ = 50%) of the ...Missing: inefficacy | Show results with:inefficacy
  88. [88]
  89. [89]
    Effectiveness and risks of cricoid pressure during rapid sequence ...
    May 16, 2022 · The results demonstrated that CP did not significantly affect the incidence of aspiration but did significantly reduce the risk of FPS. However, ...<|control11|><|separator|>
  90. [90]
    Effectiveness and risks of cricoid pressure during rapid sequence ...
    The benefit of cricoid pressure in RSI lies in preventing regurgitation and aspiration of gastric contents. However, potential risks include vocal cord closure ...Missing: 2025 | Show results with:2025
  91. [91]
  92. [92]
    Rocuronium versus succinylcholine for rapid sequence induction ...
    Overall, succinylcholine was superior to rocuronium for achieving excellent intubating conditions: RR 0.86 (95% confidence interval (CI) 0.81 to 0.92; n = 4151) ...
  93. [93]
    Sugammadex Reversal of Rocuronium Block Is Faster Than ...
    May 15, 2009 · Patients given sugammadex 3 minutes after rocuronium recover muscle function faster than those given succinylcholine alone. Rocuronium is often ...
  94. [94]
    Impact of Succinylcholine vs. Rocuronium on Apnea Duration for ...
    Feb 8, 2022 · In conclusion, this study revealed that a relatively low dose of succinylcholine and rocuronium led to a longer non-hypoxic apnea duration.
  95. [95]
    Alternatives to Rapid Sequence Intubation: Contemporary Airway ...
    Apr 26, 2019 · Ketamine, a dissociative anesthetic, can be used to facilitate two alternatives to RSI to augment airway safety in these scenarios.
  96. [96]
    No evidence for decreased incidence of aspiration after rapid ...
    Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases.Missing: prehospital | Show results with:prehospital
  97. [97]
    [PDF] Aspiration during Rapid Sequence Induction: Prevalence and Risk ...
    3 A 12–26% intubation- related adverse events have been reported in the literature. 4–6 RSI includes the use of an induction agent, followed by a paralytic ...
  98. [98]
  99. [99]
    2025 SCCM Pain, Anxiety, Agitation, Sedation, Delirium, and Sleep ...
    We suggest using dexmedetomidine over propofol for sedation in mechanically ventilated adult patients admitted to the ICU where light sedation and/or a ...